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Research
Endometriosis is a prevalent gynecologic 
disorder that is characterized by the presence 
and growth of endometrial tissue in ectopic 
sites (Giudice 2010). An equivocal body of 
evidence has emerged regarding the relation 
between lipophilic persistent organochlorine 
pollutants (POPs) and endometriosis, 
following an initial report in primates (Rier 
et al. 1993), with subsequent experimental 
evidence (Birnbaum and Cummings 2002), 
including exposures during sensitive windows 
of development (Crain et al. 2008). Three 
of seven studies that focused on dioxins or 
dioxin-like compounds and endometriosis have 
observed significantly higher concentrations 
in women with endometriosis than in those 
without the condition (Heilier et al. 2005; 
Mayani et al. 1997; Simsa et al. 2010). In 
addition, four of nine studies that focused on 
polychlorinated biphenyls (PCBs) observed 
similar findings (Gerhard and Runnebaum 
1992; Louis et al. 2005; Porpora et al. 2006, 
2009). To our knowledge, endometriosis has 
been significantly associated with only one 
class of organochlorine pesticides (OCPs): 
aromatic fungicides (Cooney et al. 2010).
The weighing of available human data is 
challenging, largely because of the nuances 
associated with the clinical diagnosis of endo-
metriosis and methodologic practices that 
affect interpretation. The clinical gold stan-
dard remains disease visualized via laparos-
copy or by laparotomy [American Society 
for Reproductive Medicine (ASRM) 2006; 
Kennedy et al. 2005]. Currently, there is no 
established noninvasive biomarker for diagno-
sis (May et al. 2010). Visualization of disease 
necessitates clinical sampling strategies that 
may exclude symptomatic women who do 
not seek care or undergo surgery, which pre-
cludes our understanding of endometriosis at 
the population level. Other widely recog  nized 
methodologic practices that affect research 
findings include convenience-based sampling, 
self-reported (yes/no) disease, varying mod-
eling practices for parity or breast-feeding 
history that may reduce internal doses of 
lipophilic POPs (LaKind et al. 2009), and 
reliance on serum or plasma in lieu of quan-
tification in fat, the presumed gold standard 
for lipophilic chemicals (Johnson-Restrepo 
et al. 2005; Whitcomb et al. 2005). We 
designed the Endometriosis: Natural History, 
Diagnosis and Outcomes (ENDO) Study to 
further delineate the relation between lipo-
philic POPs and endometriosis.
Materials and Methods
Study design and populations. A matched 
cohort design was used to estimate endometri-
osis in two cohorts. The operative cohort com-
prised menstruating women 18–44 years of age 
scheduled for a laparoscopy or laparotomy irre-
spective of indication at one of 14 participat-
ing hospital surgical centers located in the Salt 
Lake City, Utah, or San Francisco, California, 
areas between 2007 and 2009. Women were 
eligible to participate if they had no history 
of surgically visualized endometriosis (to 
reduce the likelihood of prevalent disease), no 
injectable hormone treatment within the past 
2 years, not breast-feeding for ≥ 6 months, and 
no history of cancer. The operative cohort was 
matched to a population cohort on age and 
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Ba c k g r o u n d: An equivocal literature exists regarding the relation between persistent 
  organochlorine pollutants (POPs) and endometriosis in women, with differences attributed to 
methodologies.
oBjectives: We assessed the association between POPs and the odds of an endometriosis diagnosis 
and the consistency of findings by biological medium and study cohort.
Me t h o d s : Using a matched cohort design, we assembled an operative cohort of women 18–44 
years of age undergoing laparoscopy or laparotomy at 14 participating clinical centers from 2007 to 
2009 and a population-based cohort matched on age and residence within a 50-mile catchment area 
of the clinical centers. Endometriosis was defined as visualized disease in the operative cohort and as 
diagnosed by magnetic resonance imaging in the population cohort. Logistic regression analysis was 
used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for each POP in relation to 
an endometriosis diagnosis, with separate models run for each medium (omental fat in the operative 
cohort, serum in both cohorts) and cohort. Adjusted models included age, body mass index, breast-
feeding conditional on parity, cotinine, and lipids.
re s u l t s: Concentrations were higher in omental fat than in serum for all POPs. In the operative 
cohort, γ-hexachlorocyclohexane (γ-HCH) was the only POP with a significant positive association 
with endometriosis [per 1-SD increase in log-transformed γ-HCH: adjusted OR (AOR) = 1.27; 
95% CI: 1.01, 1.59]; β-HCH was the only significant predictor in the population cohort (per 1-SD 
increase in log-transformed β-HCH: AOR = 1.72; 95% CI: 1.09, 2.72).
co n c l u s i o n s: Using a matched cohort design, we found that cohort-specific and biological-medium–
specific POPs were associated with endometriosis, underscoring the importance of methodo  logical 
considerations when interpreting findings.
key w o r d s : endocrine-disrupting chemicals, organochlorine pesticides, persistent organochlorine 
pollutants, polybrominated diphenyl ethers, polychlorinated biphenyls. Environ Health Perspect 
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residence within a 50-mile geographic catch-
ment area of the participating surgical centers. 
The sampling framework for the California 
site was sampled from the white pages of 
the telephone directory for the targeted geo-
graphic area by Genesys Sampling Systems 
(Horsham, PA), and the Utah site relied on 
the Utah Population Database (Huntsman 
Cancer Institute 2012), which represents 94% 
of state residents. Women were eligible if they 
were currently menstruating and did not have 
a history of visualized endometriosis. The pop-
ulation recruitment strategy located women 
“at risk” for endometriosis (menstruating) and 
its diagnosis at one of the participating hos-
pitals for the operative cohort (residence). In 
both cohorts, a letter of introduction preceded 
telephone screening and eventual recruitment. 
Statistical power was determined a priori as 
requiring 450 women in the operative cohort 
based on a reported endometriosis prevalence 
of 38% and a 20% relative difference in mean 
serum PCBs concentrations by endometriosis 
status (Louis et al. 2005) at the time the study 
was designed. Given the absence of previous 
population cohort studies, its size was based 
upon published studies that reported differ-
ences in POPs by endometriosis status.
Data collection. In-person baseline inter-
views were conducted with women, followed 
by anthropometric assessment using standard-
ized portable stadiometers and electronic scales 
(Lohman et al. 1988) approximately 2 months 
before surgery, or 2 months before magnetic 
resonance imaging (MRI) for the population 
cohort. For women in the operative cohort, sur-
geons completed standardized data collection 
instruments on operative findings, diagnoses, 
and staging of endometriosis using the revised 
American Society for Reproductive Medicine 
classification (ASRM 1997). An algorithm was 
used to automatically calculate endometriosis 
severity ranging from minimal to severe (stage 
1–4) to avoid bidirectional (over- and under-
staging severity) errors associated with clinical 
reporting (Buchweitz et al. 2005; Buck Louis 
et al. 2011; Weijenborg et al. 2007).
In both cohorts, nonfasting blood (~ 24 
mL) and urine (~ 120 mL) specimens were 
obtained for all women using collection kits 
determined to be free of POPs. For logisti-
cal reasons, we did not require fasting blood 
specimens. Blank containers were periodically 
sent to the analytical laboratory to check for 
contamination; none was found. Depending 
upon availability and clinical judgment about 
patient safety, 1–5 g omental fat was obtained 
from women in the operative cohort by sur-
geons. At the Utah site, Harmonic® ACE 36P 
shears and scalpel blades (donated by Ethicon 
Endo-Surgery, LLC, Cincinnati, OH) were 
used; primarily, bipolar electrocautery and 
scissors were used at the California site. Fat 
specimens were placed into Wheaton brown 
glass bottles that were cleaned with acetone 
and hexane before use. Epiploica appendiceal 
fat was obtained in lieu of omental fat for four 
women, two from each study site.
Institutional review board approval was 
obtained from all participating study sites. 
The women provided full consent before any 
data were collected, and all were remunerated 
for their time and travel. A more complete 
description of the study is provided elsewhere 
(Buck Louis et al. 2011).
Operational definitions. Endometriosis 
is defined in the operative cohort using the 
gold standard of visualization (ASRM 2006; 
Kennedy et al. 2005) and further qualified 
by histologic confirmation (endometrial 
glands or stroma and/or hemosiderin-laden 
macro  phages). In the population cohort, 
endometrio  sis diagnosed by MRI was mainly 
ovarian endometriomas.
Definitions for relevant covariates were 
as follows. Body mass index (BMI) was 
estimated by dividing measured weight in 
kilograms by height in meters squared and 
categorized as underweight (< 18.5), nor-
mal (18.5–24.9), overweight (25.0–29.9), 
obese class I (30.0–34.9), and obese class II+ 
(≥ 35.0) (National Heart, Lung, and Blood 
Institute 1998). Income was estimated using 
Department of Health and Human Services 
Poverty Guidelines (2007) for the 48 con-
tiguous states and the District of Columbia. 
Breast-feeding history was derived as a condi-
tional variable based upon parity (nulliparous/
parous) and categorized as no prior birth, 
prior birth but no breast-feeding, and prior 
birth with breast-feeding.
Toxicologic analysis. One laboratory pro-
cessed and quantified all compounds using 
gas chromatography (GC)/mass spectrometry 
(MS) with GC/electron capture detector and 
GC/high-resolution MS (HRMS) (Johnson-
Restrepo et al. 2005, 2007; Sjödin et al. 2004). 
Serum and fat samples were analyzed for three 
chemical classes of lipophilic persistent pol-
lutants: a) OCPs [hexachlorobenzene (HCB), 
hexachlorocyclohexane (HCH) and its isomers 
γ-HCH and β-HCH, oxychlordane, cis- and 
trans-nonachlor, cis- and trans-chlordane, 
and p,p´-dichlorodiphenyltrichloroethane 
(p,p´-DDT) and its metabolites p,p´-dichloro-
diphenyl  dichloro  ethylene (p,p´-DDE) and 
o,p´-DDT]; b) polybrominated diphenyl ether 
(PBDE) congeners 47, 99, 100, 153, 154, and 
209; and c) PCB congeners 18, 28, 44, 49, 52, 
66, 74, 87, 99, 101, 114, 118, 128, 138, 146, 
149, 151, 153, 156, 157, 167, 170, 172, 177, 
178, 180, 183, 187, 189, 194, 195, 196, 201, 
206, and 209. Briefly, serum samples were for-
tified with isotopically labeled internal stan-
dards along with the addition of formic acid 
(80%) and water for denaturation and dilution 
of samples using a Gilson 215 liquid hander 
(Gilson Inc., Middleton, WI).
The samples were extracted by solid-phase 
extraction (SPE) using a Rapid Trace (Caliper 
Life Science, Hopkinton, MA) modular SPE 
system. Removal of coextracted lipids was 
performed on a silica: silica/sulfuric acid col-
umn using Rapid Trace equipment for auto-
mation. Final analytical determination of the 
target analytes was performed by GC/isotope-
dilution HRMS employing a Thermo Finnigan 
MAT95XP (Thermo Fisher Scientific, Bremen, 
Germany). External calibration standards 
were analyzed with every set of samples, and 
recoveries of internal standards were checked 
against external calibration standards. Three 
blanks were included in every batch compris-
ing 30 samples. Fat samples were extracted 
by the Soxhlet extraction procedure, and fur-
ther details of the methods are given elsewhere 
(Johnson-Restrepo et al. 2005, 2007).
All concentrations are reported in nano-
grams per gram of fat or serum after sub-
tracting background. All machine-observed 
concentrations were used without any substi-
tution of concentrations below the limits of 
detection (LODs) to avoid introducing biases 
(Guo et al. 2010; Richardson and Ciampi 
2003; Schisterman et al. 2006). Serum lipids 
were analyzed with enzymatic methods (Akins 
et al. 1989). Total serum lipids (TL) were 
estimated as
TL = (2.27 × TC) + TG + 62.3 mg/dL,
where TC denotes total cholesterol and TG 
denotes triglycerides, and were reported in 
milli  grams per deciliter (Philips et al. 1989). 
Serum cotinine was quantified using high-
performance liquid chromatography/tandem 
MS using an isotope dilution method and 
external standard calibration plots (Bernert 
et al. 2009). Serum cotinine was further cat-
egorized as noted above to help identify pas-
sive and active exposure using established 
cut-points (Wall et al. 1988).
Statistical analysis. The distributions of 
all chemicals were inspected and summa-
rized by geometric means and 95% confi-
dence intervals (CIs) and percentiles (median, 
75th, 95th). Comparisons of select variables 
by cohort and endometriosis status were 
made to assess a priori defined select vari-
ables (i.e., age, BMI, serum cotinine, and 
lipids) for the analytic phase. Statistical sig-
nificance (p < 0.05) was determined using the 
chi-square statistic for categorical data and 
Student’s t-test or Wilcoxon nonparametric 
test for continuous data.
Logistic regression was used to estimate 
the unadjusted odds ratio (OR) and corre-
sponding 95% CI for each chemical by 
biological medium and cohort. CIs that 
excluded 1 were considered significant. 
All chemical concentrations were first log 
(X + 1)-transformed to achieve normality and Persistent environmental chemicals and endometriosis
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then rescaled by their standard deviations 
so that ORs could be interpreted per 1-SD 
change in the log-transformed chemical 
concentration. All analy  ses used wet-weight 
concentrations. Adjusted models included age 
(in years), breast-feeding history (conditional 
categorical), BMI (continuous), and cotinine 
(continuous) (Hediger et al. 2005; Nelson 
et al. 2006; Sasamoto et al. 2006; Zeyneloglu 
et al. 1997). Serum lipids (milli  grams per 
deciliter) were also entered into serum models 
to minimize potential biases associated with 
automatic lipid adjustment (Schisterman et al. 
2005). We also adjusted for breast-feeding 
conditional on parity, given its uncertain 
relation with endometriosis. In addition, we 
conducted a number of sensitivity analyses to 
assess the consistency of findings by removing 
parity and breast-feeding from models, 
varying the diagnostic criteria to require both 
histologic and visualized disease, restricting 
diagnosis to endometriosis stages 3–4, and 
restricting the comparison group to women 
with a postoperative diagnosis of a normal 
pelvis in the operative cohort. All analyses were 
conducted using SAS software (version 9.2; 
SAS Institute Inc., Cary, NC).
Results
The operative cohort comprised 495 women 
scheduled for surgery, and the population 
cohort comprised 131 women, represent-
ing 77% and 79% of eligible women in the 
target populations, respectively. Twenty-six 
women had no diagnostic information stem-
ming from the cancellation of 22 (4%) surger-
ies or 4 (4%) unreadable MRIs in the operative 
and population cohorts, respectively, and were 
excluded from all analyses. Despite their differ-
ent sampling frameworks, few differences were 
observed between cohorts (data not shown), 
with the exception of a higher percentage of 
married women in the operative than in the 
population cohort (76% vs. 60%, respectively), 
as previously reported (Buck Louis et al. 2011). 
The incidence of surgically visualized endo-
metriosis was 41% in the operative cohort, 
whereas MRI-visualized endometriosis was 
11% in the population cohort. Most of the 
cases in the operative cohort were not severe: 
71% had stage 1 or 2, and 29% had stage 3 
or 4. However, differences were observed by 
disease status. In the operative cohort, women 
with endometriosis were significantly younger, 
of lower parity, and leaner than women with-
out endometriosis (Table 1). In the population 
cohort, women with endometriosis were com-
parable to women without disease, with one 
important difference—the absence of smokers 
among women with endometriosis (Table 1).
Table 2 presents the distributions of POPs 
by biological medium and disease status for 
each of the cohorts. Two differences emerged: 
a) the upper bound of all tertiles based on 
wet-weight concentrations was higher for the 
sum of OCPs (ΣOCPs), ΣPBDEs, and ΣPCBs 
when measured in fat than when measured 
in serum, and b) the geometric mean serum 
PBDE and PCB concentrations were slightly 
higher in women without versus women 
with endometriosis in the operative cohort, 
whereas the opposite pattern was observed 
for the popu  lation cohort. Significant mean 
differences in ΣPBDEs measured in fat 
were observed for the operative cohort, with 
higher concentrations for women without 
endometrio  sis than for women with endo-
metriosis. The reverse pattern was observed for 
the population cohort for mean ΣPBDEs in 
serum. No other patterns were evident for the 
remaining POPs by endometriosis status. The 
distributions for all individual chemicals by 
biological medium, cohort, and endometriosis 
status are provided in Supplemental Material, 
Tables 1 and 2 (http://dx.doi.org/10.1289/
ehp.1104432). Lipid adjusted fat and 
serum concentrations also are provided in 
Supplemental Material, Table 3.
Table 3 presents the logistic regres-
sion results for each chemical observed to be 
significantly associated with the odds of an 
endometriosis diagnosis in each cohort and 
by biological medium. Results for all chemi-
cals not achieving significance are provided in 
Supplemental Material, Table 4 (http://dx.doi.
org/10.1289/ehp.1104432). Several note-
worthy patterns emerged, including the absence 
of consistent chemical effects across biologi-
cal media or cohorts and a modest attenua-
tion in the magnitude of point estimates after 
adjustment, although with no change in the 
direction of the adjusted ORs (AORs). In the 
operative cohort, where chemicals could be 
measured in fat, γ-HCH was positively associ-
ated with endometriosis (per 1-SD increase: 
AOR = 1.27; 95% CI: 1.01, 1.59). Of note are 
the three compounds associated with reduced 
odds of diagnosis: PBDE-47 (AOR = 0.70; 
95% CI: 0.55, 0.90), PCB-74 (AOR = 0.72; 
95% CI: 0.55, 0.93), and PCB-156 (AOR = 
0.74; 95% CI: 0.57, 0.96). Serum β-HCH 
was the only POP that showed a statistically 
signficant association with endometriosis in the 
population cohort (per 1-SD increase: AOR = 
1.72; 95% CI: 1.09, 2.72).
We conducted a number of sensitiv-
ity analyses to assess the robustness of our 
primary findings, given different modeling 
assumptions (data not shown). Given the 
uncertain role of breast-feeding and parity in 
Table 1. Characteristics and endometriosis status of study cohorts [n (%)], ENDO Study (n = 600].
Operative (n = 473) Population (n = 127)
Characteristic
Endometriosis  
(n = 190)
None  
(n = 283)
Endometriosis 
(n = 14)
None  
(n = 113)
Age (years)
< 30 75 (40) 88 (31) 5 (36) 47 (41)
30–39 83 (44) 120 (43) 5 (36) 40 (35)
≥ 30 32 (17) 74 (26) 4 (29) 26 (23)
Mean ± SD 32.0 ± 6.8* 33.6 ± 7.1 33.1 ± 8.3 32.1 ± 7.8
Parity (no. of live births)
Never been pregnant 81 (43) 74 (26) 5 (36) 46 (41)
0 22 (12) 25 (9) 1 (7) 10 (9)
1 21 (11) 40 (14) 1 (7) 11 (10)
≥ 2 66 (35) 142 (51) 7 (50) 46 (41)
Mean ± SDa 1.8 ± 1.3* 2.2 ± 1.4 2.6 ± 1.6 2.2 ± 1.5
Breast-feeding conditional on parity
No, nulliparous 103 (55) 101 (36) 6 (43) 56 (50)
No, parous 20 (11) 37 (13) 1 (7) 9 (8)
Yes, parous 65 (34) 144 (51) 7 (50) 48 (42)
Mean ± SDb 5.0 ± 5.5 5.3 ± 4.9 8.3 ± 2.2 7.5 ± 5.6
BMI (kg/m2)
< 18.5 8 (4) 5 (2) 1 (7) 7 (6)
18.5–24.9 97 (51) 93 (33) 6 (43) 45 (40)
25.0–29.9 39 (21) 70 (25) 4 (29) 29 (26)
30.0–34.9 17 (9) 56 (20) 1 (7) 16 (14)
≥ 35 28 (15) 55 (20) 2 (14) 16 (14)
Mean ± SD 26.3 ± 7.2** 29.2 ± 8.4 27.4 ± 9.0 27.0 ± 6.7
Cotinine (ng/mL)c
No exposure (0–9.99) 168 (89) 230 (82) 14 (100) 97 (89)
Passive smoking (10–99.99) 8 (4) 16 (6) 0 (0) 5 (5)
Active smoking (100–299.99) 11 (6) 30 (11) 0 (0) 7 (6)
Heavy smoking (300–595.31) 2 (1) 4 (1) — —
Mean ± SD for smokers 152.5 ± 105.8 168.3 ± 110.3 — 113.2 ± 101.3
A total of 22 women in the operative cohort were excluded because their surgeries were canceled, and 4 women in the 
population cohort were excluded because their MRIs were unreadable. None of the differences in the population cohort 
achieved significance. 
aRestricted to 394 gravid women. bRestricted to 264 parous women who breast-fed.   cCategorization of cotinine by active 
and passive smoking status based on criteria of Wall et al. (1988). *p < 0.05, and **p < 0.01, comparing endometriosis 
status within cohort.Buck Louis et al.
814  v o l u m e  120 | n u m b e r 6 | June 2012  •  Environmental Health Perspectives
the etiologic pathway, we removed it from 
the model and observed similar associations 
for fat γ-HCH (AOR = 1.26; 95% CI: 1.00, 
1.58) and serum β-HCH (AOR = 1.70; 95% 
CI: 1.08, 2.66) in the operative and popula-
tion cohorts, respectively. A reversal in the 
direction of the AOR was observed for fat 
γ-HCH when restricting the endometrio-
sis to include visualization and histology 
(AOR = 0.86; 95% CI: 0.57, 1.28) and to 
stages 2 and 4 (AOR = 0.86; 95% CI: 0.47, 
1.55). The AOR remained elevated for fat 
γ-HCH (AOR = 1.31; 95% CI: 0.96, 1.79) 
when restricting the comparison women 
to those with a postoperative diagnosis of a 
normal pelvis. We also noted an association 
with two other POPs in this analysis using fat 
concentrations: a) PBDE-183 (AOR = 1.55; 
95% CI: 1.06, 2.26) and b) PCB-151 
(AOR = 3.23; 95% CI: 1.43, 7.28).
Discussion
We observed two previously unreported POPs 
(γ-HCH and β-HCH) to be associated with 
an increased odds of an endometriosis diag-
nosis in the operative and population cohorts, 
respectively. Our findings for HCH isomers 
were robust to adjustment, although with 
some reduction in magnitude. All remain-
ing POPs varied by cohort and biological 
medium. Also of note is the observation that 
three POPs (i.e., PBDE-47, PCB-74, and 
PCB-156) measured in fat were inversely 
associated with the odds of an endometriosis 
diagnosis in the operative cohort.
The novel use of a matched cohort design 
allowed us to assess the consistency of find-
ings by study cohort, diagnostic method, 
and biological medium. Our inconsistent 
findings across study cohorts and biological 
media suggest the importance of such factors 
when attempting to weigh available evidence. 
Because women in the population cohort did 
not undergo laparoscopies, we cannot assess 
chemical profiles of fat across cohorts. We 
did attempt to compare our omental fat con-
centrations with the sole previous study that 
quantified PCBs in serum and fat and noted 
lower concentrations for our cohort (Louis 
et al. 2005). This may reflect more nulligravid 
women coupled with a limited (n = 15) num-
ber of omental fat samples analyzed in the 
earlier study relative to ours, along with dif-
ferent laboratory analytic methods. Our find-
ings do corroborate higher concentrations in 
fat relative to lipid-adjusted serum concentra-
tions consistent with their lipophilicity (Allam 
and Lucena 2001; Johnson-Restrepo et al. 
2005; Whitcomb et al. 2005). Fat concentra-
tions reflect steady-state concentrations that 
integrate lipophilic chemicals accumulated 
over time. They reflect body burdens that are 
less affected by factors that may affect serum 
concentrations. Use of proxy biospecimens 
for lipophilic chemicals may mask or mini-
mize health effects, as suggested by the lack 
of consistent findings across biological media 
irrespective of cohort, and may account for 
equivocal findings published to date.
We assessed the impact of diagnostic 
method for endometriosis in relation to the 
inconsistency of study findings across cohorts. 
MRI-diagnosed endometriosis may have 
limited sensitivity and specificity relative to 
visualization depending upon the presence of 
classical or atypical lesions and disease severity 
(Stratton et al. 2003). Therefore, we conducted 
sensitivity analyses to restrict endometrio-
sis to stages 3 and 4 and observed no asso-
ciation with β-HCH in the operative cohort 
(AOR = 0.68; 95% CI: 0.28, 1.66). Also of 
note was the change in direction for γ-HCH 
(AOR = 0.86; 95% CI: 0.57, 1.28) when diag-
nosis was restricted to histologic and visualized 
disease. These findings suggest that γ-HCH 
may be associated with milder rather than 
more severe disease, or they may reflect the fra-
gility of models given the reduction in power 
and bidirectional errors in clinical staging of 
endometriosis. Further study of HCH is war-
ranted, given the relatively consistent findings 
for its positive association with endometriosis 
across cohorts, although with different isomers 
emerging for each cohort. Such differences may 
reflect the toxicologic properties (γ-HCH is 
more toxic than β-HCH) or bioaccumulation 
potential (β-HCH is more bioaccumulative 
than γ-HCH) of HCH isomers. The findings 
await future corroboration.
The emergence of two other POPs—
PBDE-183 and PCB-151—when restricting 
the referent group to women with a postoper-
ative report of a normal pelvis as a part of our 
sensitivity analyses is intriguing. This find-
ing underscores the importance of ensuring 
Table 2. Chemical distributions (wet weight) by cohorts and endometriosis status [n (%)], ENDO Study 
(n = 600).
Operative (n = 473) Population (n = 127)
Biological medium and 
chemical grouping (tertiles)
Endometriosis 
(n = 190)
None 
(n = 283)
Endometriosis 
(n = 14)
None 
(n = 113)
Omental fat (n = 340)
ΣOCPs (ng/g fat)
1st, 0.17–7.20 50 (34) 62 (33) — —
2nd, 7.22–13.74 50 (34) 62 (33) — —
3rd, 13.86–103.85 46 (32) 67 (35) — —
Geometric mean (95% CI) 9.11 (7.72, 10.74) 9.69 (8.55, 10.97) — —
ΣPBDEs (ng/g fat)
1st, 2.11–26.41 62 (42)** 51 (26) — —
2nd, 26.43–70.69 51 (35) 62 (32) — —
3rd, 70.82–3295.72 34 (23) 80 (42) — —
Geometric mean (95% CI) 36.41 (30.91, 42.89)** 52.73 (44.95, 61.86) — —
ΣPCBs (ng/g fat)
1st, 3.80–22.25 40 (27)* 73 (38) — —
2nd, 22.41–43.19 60 (41) 53 (27) — —
3rd, 43.52–1855.19 46 (32) 68 (35) — —
Geometric mean (95% CI) 31.71 (27.59, 36.45) 31.10 (27.46, 35.21) — —
Serum (n = 599)
ΣOCPs (ng/g serum)
1st, 0.00–0.01 63 (33) 95 (34) 3 (21) 34 (30)
2nd, 0.01–0.02 66 (35) 88 (31) 7 (50) 43 (38)
3rd, 0.02–0.81 60 (32) 100 (35) 4 (29) 36 (32)
Geometric mean (95% CI)a 0.01 (0.01, 0.01) 0.01 (0.01, 0.01) 0.01 (0.00, 0.03) 0.01 (0.01, 0.01)
ΣPBDEs (ng/g serum)
1st, 0.00–0.10 74 (39) 89 (31) 2 (14)* 34 (30)
2nd, 0.11–0.18 61 (32) 93 (33) 5 (36) 41 (36)
3rd, 0.19–4.95 54 (29) 101 (36) 7 (50) 38 (34)
Geometric mean (95% CI) 0.13 (0.11, 0.15) 0.14 (0.13, 0.16) 0.28 (0.16, 0.51)* 0.15 (0.13, 0.18)
ΣPCBs (ng/g serum)
1st, 0.00–0.15 69 (37) 93 (33) 5 (36) 32 (28)
2nd, 0.16–0.57 63 (33) 90 (32) 2 (14) 45 (40)
3rd, 0.58–391.78 57 (30) 100 (35) 7 (50) 36 (32)
Geometric mean (95% CI) 0.26 (0.20, 0.33) 0.30 (0.25, 0.37) 0.32 (0.15, 0.69) 0.31 (0.24, 0.40)
ΣSerum lipids (mg/dL)
1st, 316.63–548.9 62 (33) 91 (33) 7 (54) 35 (33)
2nd, 549.28–653.68 64 (34) 95 (34) 3 (23) 33 (31)
3rd, 654.09–1631.52 61 (33) 93 (33) 3 (23) 39 (36)
Geometric mean (95% CI) 593.9 (577.3, 610.9) 609.7 (594.8, 624.9) 575.3 (504.7, 655.9) 609.0 (583.7, 635.4)
—, not applicable (no fat available for population cohort). A total of 22 women in the operative cohort were excluded 
because their surgeries were canceled, and 4 women in the population cohort were excluded because their MRIs were 
unreadable. Analyte concentrations rounded to two decimal places.
aCorresponding four-decimal-point values are 0.0090 (0.0072, 0.0112), 0.0097 (0.0081, 0.0116), 0.0114 (0.0045, 0.0290), and 
0.0100 (0.0077, 0.0132), respectively. *p < 0.05, and **p < 0.01, comparing women by endometriosis status within each 
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that the comparison group undergoes surgical 
visualization to identify women with no endo-
metriosis or other gynecologic pathology. This 
finding may suggest a possible shared etiol-
ogy for endometriosis and other gynecologic 
disorders for some POPs, although a more 
complete understanding is not possible with-
out purposefully designed research aimed at 
addressing this question.
We present novel findings of an association 
between lipophilic HCH isomers and endo-
metriosis. HCH production and sale ceased in 
the United States in 2007, with earlier restric-
tions for agriculture use (Agency for Toxic 
Substances and Disease Registry 2005). γ-HCH 
has a shorter half-life than does β-HCH (~2 
weeks and 7 years, respectively) resulting in 
human exposure, which may be declin-
ing except for select subpopulations (Becker 
et al. 2002; Centers for Disease Control and 
Prevention 2009; Stehr-Green 1989). Further 
interpretation of our findings in the context of 
past literature is challenging, because no two 
studies are directly comparable. Pregnancy and 
breast-feeding history affects internal dose of 
POPs and may result in concentration dif-
ferences for women with and without visual-
ized endometriosis. This is particularly true if 
the former group has fewer pregnancies and 
breast-feeding intervals relative to unaffected 
women. Because some POPs were associated 
with reduced fecundity (Harley et al. 2010; 
Meeker et al. 2011), we included a condi-
tional breast-feeding variable in our models to 
adjust for reproductive histories and observed 
little change in the estimates. Also, serum PCB 
concentrations are reported to decline through-
out pregnancy (Glynn et al. 2011), particularly 
when modeled as a function of women’s base-
line exposures (Bloom et al. 2007).
We were able to locate reports of some 
studies that focused on OCPs but not PBDEs. 
Lebel et al. (1998) reported higher geomet-
ric mean concentrations for six of nine mea-
sured OCPs, including β-HCH, for women 
with endometriosis (n = 86) compared with 
women without endometriosis (n = 70), 
although none of the differences achieved sig-
nificance, possibly a function of overmatching 
the comparison women on surgical indication. 
Trabert et al. (2010) reported comparable 
median serum DDE concentrations by endo-
metriosis status consistent with our observa-
tion. Lastly, Cooney et al. (2010) reported 
that women in the third versus first tertile of 
serum HCB were significantly more likely to 
have surgically visualized endometriosis.
The exact mechanisms by which POPs 
may influence the development of endo-
metriosis remain unknown, although several 
pathways have been suggested, such as potent 
modulation of immune and endocrine func-
tion (Rier and Foster 2002). Human endo-
metrium is a known site for estrogen, and 
many POPs or their metabolites have been 
detected there (Schaefer et al. 2000). POPs 
may exert effects on estrogen or other hor-
monal production, or induce inflammation 
and the chronic stimulation of proinflamma-
tory cytokines. Both PCBs and DDE have 
been associated with immunologic changes, 
such as the down-regulation of natural killer 
cells or interleukin-1β and interleukin-12 
(Quaranta et al. 2006).
Our study has important limitations, 
including a relatively limited population cohort 
size, of which 11% of women were found to 
have endometriosis, and possible selection bias 
arising from the use of telephone directories for 
defining the population cohort recruited from 
California. The extent to which such directories 
represent the female populations for the refer-
ent population is unknown. The lack of major 
differences between cohorts may simply reflect 
who participates in research irrespective of sam-
pling framework rather than selection factors 
per se. Other study limitations include the lack 
of quantified dioxin exposure, given its sugges-
tive association with endometriosis (Eskenazi 
et al. 2002), and our inability to establish the 
timing and temporal ordering of fat and serum 
concentrations relative to development of dis-
ease, including a possible in utero origin (Buck 
Louis et al. 2010; Signorile et al. 2010). We 
are unaware of any human data specifying the 
interval between exposure and disease onset, 
although it was estimated to be 7–10 years in 
rhesus monkeys (Rier et al. 1993). The dynamic 
nature of endometriosis, often characterized by 
periods of disease progression and regression, 
further challenges our ability to delineate initiat-
ing events or to diagnosis truly incident disease 
(D’Hooghe et al. 1992; Redwine 1987).
Conclusions
Two new POPs from the same chemical class, 
γ-HCH and β-HCH, were associated with 
increased odds of an endometriosis diagnosis 
Table 3. Summary of persistent lipophilic chemicals significantly associated with the odds of an endometriosis diagnosis by biological media and cohorts, ENDO 
Study (n = 600).
OR (95% CI) AOR (95% CI)
Biological medium and 
chemical grouping
LOD 
(% < LOD)
SDs 
(operative/population)
Operative cohort 
(n = 473)
Population 
cohort (n = 127)
Operative cohort 
(n = 473)
Population 
cohort (n = 127)
Fat (ng/g fat)
OCPs
γ-HCH 0.060 (12) 0.27/— 1.35 (1.03, 1.77) — 1.27 (1.01, 1.59) —
PBDEs
PBDE-47 0.100 (0) 1.034/— 0.68 (0.54, 0.86) — 0.70 (0.55, 0.90) —
PBDE-183 1.200 (68) 0.852/— 1.30 (1.04, 1.62) — 1.21 (0.96, 1.52) —
ΣPBDEs 1.055/— 0.70 (0.56, 0.88) — 0.69 (0.54, 0.88) —
PCBs
PCB-28 0.065 (37) 0.519/— 1.30 (1.04, 1.62) — 1.16 (0.92, 1.47) —
PCB-74 0.030 (7) 0.691/— 0.77 (0.61, 0.96) — 0.72 (0.55, 0.93) —
PCB-151 0.030 (30) 0.099/— 1.31 (1.03, 1.67) — 1.25 (0.99, 1.56) —
PCB-156 0.030 (20) 0.665/— 0.78 (0.62, 0.98) — 0.74 (0.57, 0.96) —
PCB-201 0.030 (16) 0.170/— 1.28 (1.03, 1.60) — 1.20 (0.94, 1.53) —
Serum (ng/g serum)
Cotinine 0.010 (38) 1.755/1.432 0.80 (0.66, 0.98) 0.34 (0.04, 3.12) 0.85 (0.69, 1.05) 0.34 (0.04, 3.06)
OCPs
β-HCH 0.010 (64) 0.044/0.016 0.76 (0.54, 1.07) 1.52 (1.01, 2.29) 0.77 (0.54, 1.14) 1.72 (1.09, 2.72)
PBDEs
ΣPBDEs 0.208/0.209 0.87 (0.71, 1.06) 1.64 (1.08, 2.50) 0.90 (0.72, 1.11) 1.58 (0.97, 2.57)
PCBs
PCB-206 0.003 (68) 0.007/0.008 0.79 (0.65, 0.95) 1.10 (0.66, 1.83) 0.79 (0.65, 0.97) 1.19 (0.72, 1.95)
—, not applicable (no fat available for population cohort). A total of 22 women from the operative cohort were exclucded because their surgeries were canceled, and 4 women from 
the population cohort were excluded because their MRIs were not readable. Concentrations were log(X + 1)-transformed, rescaled by their SDs for analysis, and adjusted for age 
(years), BMI (continuous), breast-feeding (categorical, conditional on parity), serum cotinine (continuous), and serum lipids (continuous, milligrams per deciliter). SDs were derived for 
each cohort based on the log-transformed concentrations. Buck Louis et al.
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in each the operative and population cohorts, 
respectively. The findings were largely robust 
to model specification and choice of referent 
population for the operative cohort.
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